Long-term Efficacy of Erenumab in Patients with Chronic Migraine Who Failed Prior Prophylactic Treatment

被引：0

作者：

Ashina, M. ^{[1
]}

Tepper, S. J. ^{[2
]}

Brandes, J. ^{[3
]}

Boudreau, G. ^{[4
]}

Dolezil, D. ^{[5
]}

Klatt, J. ^{[6
]}

Zhang, F. ^{[7
]}

Cheng, S. ^{[7
]}

Mikol, D. D. ^{[7
]}

机构：

[1] Rigshosp Glostrup, Glostrup, Hovedstaden, Denmark

[2] Dartmouth Hitchcock Med Ctr, Dept Neurol, Lebanon, NH 03766 USA

[3] Nashville Neurosci Grp, Nashville, TN USA

[4] Ctr Traitement Neurol, Montreal, PQ, Canada

[5] Prague Headache Ctr, Prague, Jihocesky Kraj, Czech Republic

[6] Novartis Pharma AG, Basel, Basel Stadt, Switzerland

[7] Amgen Inc, Thousand Oaks, CA USA

来源：

HEADACHE | 2018年 / 58卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

PF106LB

引用

页码：1296 / 1297

页数：2

共 50 条

[11] Long-term efficacy of fremanezumab in chronic and episodic migraine patients who failed at least one prior migraine preventive medication: results of a 1-year study
Winner, Paul K.
Freeman, Marshall C.
Cohen, Joshua M.
Yang, Ronghua
Ning, Xiaoping
Blaiss, Cory
CEPHALALGIA, 2019, 39 : 36 - 37
[12] Efficacy of erenumab in chronic migraine patients with medication overuse and prior preventive treatment failure
Dodick, D.
Tepper, S.
Diener, H. -C.
Tassorelli, C.
Lucas, S.
Evers, S.
Zhang, F.
Chou, D.
Tenenbaum, N.
Klatt, J.
Mikol, D.
Lima, G.
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 811 - 811
[13] Efficacy of Erenumab in Chronic Migraine Patients with Medication Overuse and Prior Preventive Treatment Failure
Dodick, David
Tepper, Stewart J.
Diener, Hans Christoph
Tassorelli, Cristina
Lucas, Sylvia
Evers, Stefan
Zhang, Feng
Chou, Denise
Tenenbaum, Nadia
Klatt, Jan
Mikol, Daniel
Lima, Gabriel Paiva da Silva
NEUROLOGY, 2019, 92 (15)
[14] Long-term efficacy of erenumab in chronic migraine (CM) patients with or without acute medication overuse (AMO)
Tepper, Stewart
Lipton, Richard
Silberstein, Stephen
Kudrow, David
Ashina, Messoud
Reuter, Uwe
Dodick, David
Zhang, Feng
Cheng, Sunfa
Mikol, Daniel
NEUROLOGY, 2020, 94 (15)
[15] Efficacy of erenumab for the treatment of patients with chronic migraine and aura
Ashina, Messoud
Dodick, David
Goadsby, Peter J.
Kudrow, David
Reuter, Uwe
Tepper, Stewart J.
Cheng, Sunfa
Leonardi, Dean
Lenz, Robert A.
Mikol, Daniel D.
CEPHALALGIA, 2017, 37 : 34 - 35
[16] Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis
Tepper, Stewart J.
Lipton, Richard B.
Silberstein, Stephen D.
Kudrow, David
Ashina, Messoud
Reuter, Uwe
Dodick, David W.
Wang, Andrea
Cheng, Sunfa
Klatt, Jan
Mikol, Daniel D.
HEADACHE, 2023, 63 (06): : 730 - 742
[17] Conversion from Chronic Migraine (CM) to Episodic Migraine (EM) with long-term erenumab treatment
Lipton, R. B.
Tepper, S. J.
Silberstein, S.
Kudrow, D.
Ashina, M.
Reuter, U.
Dodick, D.
Cheng, S.
Rippon, G. A.
Zhang, F.
Mikol, D. D.
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 636 - 636
[18] Conversion from Chronic Migraine (CM) to Episodic Migraine (EM) With Long-Term Erenumab Treatment
Lipton, Richard
Tepper, Stewart
Silberstein, Stephen
Kudrow, David
Ashina, Messoud
Reuter, Uwe
Dodick, David
Cheng, Sunfa
Rippon, Gregory
Zhang, Feng
Mikol, Daniel
NEUROLOGY, 2019, 92 (15)
[19] Assessment of the Long-term Safety and Efficacy of Erenumab During Open-label Treatment of Subjects with Chronic Migraine
Tepper, S. J.
Ashina, M.
Brandes, J.
Dolezil, D.
Silberstein, S. D.
Winner, P. K.
Zhang, F.
Cheng, S.
Mikol, D. D.
HEADACHE, 2018, 58 (08): : 1302 - 1303
[20] Assessment of the long-term safety and efficacy of erenumab during open-label treatment of subjects with chronic migraine
Tepper, Stewart
Ashina, Messoud
Reuter, Uwe
Brandes, Jan L.
Dolezil, David
Silberstein, Stephen
Winner, Paul
Zhang, Feng
Cheng, Sunfa
Mikol, Daniel
JOURNAL OF HEADACHE AND PAIN, 2018, 19

← 1 2 3 4 5 →